The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ARCHIVE
ARCHIVE
- EAD Director Calls For Fair Trade Practices for Ethical Drugs
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
June 11, 2001
- Sankyo's Olmesartan More Effective than Other ARBs: Study
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
June 11, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
June 11, 2001
- Proposed Drug Classification Gives Top Priority to Clinical Usage
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -4-
June 11, 2001
- Implementation Working Group Formed for Coordinated Application of CTD
June 11, 2001
- 4 of 10 Listed Wholesalers Report Losses
June 11, 2001
- Korosho Official Explains Criteria for Disclosure or Non-disclosure
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -5-
June 11, 2001
- Japan-EU Mutual GMP Recognition Treaty Approved by Lower House
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -6-
June 11, 2001
- REGULATORY NEWS IN BRIEF -1-
June 11, 2001
- AstraZeneca Introduces Mentoring System
June 11, 2001
- REGULATORY NEWS IN BRIEF -2-
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -7-
June 11, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 11, 2001
- Sysmex: Sales Down in US, Japan, but Up in Europe, Asia
June 11, 2001
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…